Senior Interventionist Supervisor Position:
06/24/2008
Kaiser Permanente Center for Health Research is recruiting for the position of Senior Interventionist Supervisor. This position is responsible for supervising all the staff in the Health Behavior Unit of the Behavior Assessment and Change Department of the Center for Health Research. Supervisory duties include supervising and evaluating personnel performance, orienting and training staff to department and agency policies and procedures, as well as to research assessment and intervention procedures. The supervisor will be responsible for developing and overseeing quality improvement and productivity monitoring procedures. He/She will monitor FTE needs of projects who use staff within the Health Behavior unit and work with project managers and investigators to make appropriate adjustments.
In addition to supervisory responsibilities, the Senior Interventionist Supervisor is responsible for conducting a variety of intervention and Lead Interventionist responsibilities on research projects.
The position is funded as a mix of administrative funding (25% - 35%) and direct project funding (65% - 75%).
For details about the positions see the job posting (# 71655) at the KP site below, or contact:
Mark Spofford, Ph.D.
Manager, Behavior Services and Community Based Research
Kaiser Permanente Center for Health Research
3800 N. Interstate Ave.
Portland, OR 97227-1110
(503) 335-6334
mark.spofford@kpchr.org
|
|
RARE DISEASES CLINICAL RESEARCH CONSORTIA (RDCRC) FOR THE RARE DISEASES CLINICAL RESEARCH NETWORK
03/21/2008
The NIH ORD, NIAMS, NIDDK, NICHD, NINDS, NIA ,NIAAA, NCI, NIDCR and NHLBI invite new and renewal applications (U54) for Rare Diseases Clinical Research Consortia (RDCRC) component of Rare Diseases Research Network (RDCRN). The purpose of this cooperative agreement research program is to facilitate clinical research in rare diseases through support for:
1) collaborative clinical research in rare diseases, including longitudinal studies of individuals with rare diseases, clinical studies, and/or phase I, II and II/III trials;
2) training of clinical investigators in rare diseases research; 3) pilot and demonstration projects;
4) a test bed for distributed clinical data management that incorporates novel approaches and technologies for data management, data mining, and data sharing across rare diseases, data types, and platforms; and
5) access to information related to rare diseases for basic and clinical researchers, academic and practicing physicians, patients, and the lay public.
Each RDCRC will perform collaborative clinical research in rare diseases, train new investigators in rare diseases research, and provide content for an internet resource site on rare diseases. Each RDCRC will consist of a consortium of clinical investigators, institutions, and relevant organizations, including patient support organizations, focused on a subgroup of rare diseases. Use of the resources available at institutions with a Clinical and Translational Science Award (CTSA) or General Clinical Research Center (GCRC) should be incorporated into each RDCRC if available at the applicants’ institutions. The focus of each RDCRC can be on particular defects, e.g., lysosomal storage diseases, amino acid metabolism defects; particular organ systems, e.g., primary immune deficiencies, mental retardation syndromes; or other groupings. Since rare diseases are diverse, the nature of clinical research that is feasible varies. The application must describe the group of rare diseases to be included, the rationale for this grouping, and the relevant expertise available in the proposed RDCRC. The individual RDCRCs will be responsible for the design and implementation of their clinical studies. The Data Management and Coordinating Center (DMCC), formerly called Data Technology Coordinating (DTCC) will provide the data management and analysis infrastructure and support necessary for the RDCRCs to function optimally. The DMCC will work with each Consortium to integrate protocols, forms, and research tools into the Network. Rare Disease RFA
|
|